Press release
Methylmalonic Acidemia Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies -Logic Biotherapeutics, Moderna, HemoShear Therapeutics, Target Pharma Solutions.
Methylmalonic Acidemia Market
Download Sample Report to know more @ https://www.delveinsight.com/sample-request/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Methylmalonic Acidemia Overview
Methylmalonic acidemia is a disorder in which the body cannot break down certain proteins and fats. The result is a buildup of a substance called methylmalonic acid in the blood. This condition is passed down through families. It is one of several conditions called an "inborn error of metabolism. There are two types of methylmalonic acidemia (MMA): cobalamin disorders and MUT deficiencies. One of the ways these two types of MMA differ is their response to vitamin B-12. MUT deficiencies are considered non-vitamin B-12 responsive. Cobalamin deficiencies are vitamin B-12 responsive.
Learn more about Methylmalonic Acidemia @ https://www.delveinsight.com/report-store/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The key Methylmalonic Acidemia companies working in the treatment landscape include Logic Biotherapeutics, Moderna, HemoShear Therapeutics, Target Pharma Solutions, and many others.
The key Methylmalonic Acidemia therapies in the pipeline include hLB-001, HST5040, SEL-302, BBP-671, and many others.
Methylmalonic Acidemia Treatment Market
Medication treatment consists cobalamin (vitamin B12) given as an injection, carnitine, and antibiotics. The diet is protein restricted to limit the intake of isoleucine, threonine, methionine, and valine because these substances can turn into methylmalonic acid in an affected patient
Learn more about the treatment market for the report
https://www.delveinsight.com/report-store/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Methylmalonic Acidemia Epidemiology Segmented by:
Methylmalonic Acidemia Prevalent cases
Methylmalonic Acidemia Incident Cases
Methylmalonic Acidemia treatment cases
Methylmalonic Acidemia Diagnosed cases
Methylmalonic Acidemia Dug Profile and Companies Covered
Logic Biotherapeutics- hLB-001
HemoShear Therapeutics- HST5040
CoA Therapeutics- SEL-302
Sanofi- BBP-671
And many others.
Learn more about the Key Companies and Emerging Therapies @https://www.delveinsight.com/sample-request/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Methylmalonic Acidemia Introduction
Executive Summary of Methylmalonic Acidemia
Disease Background and Overview
Methylmalonic Acidemia Epidemiology and patient population
Methylmalonic Acidemia Emerging Therapies
Methylmalonic Acidemia Market Outlook
Methylmalonic Acidemia Market Access and Reimbursement of Therapies
Methylmalonic Acidemia Market Drivers
Methylmalonic Acidemia Market Barriers
Appendix
Methylmalonic Acidemia Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @https://www.delveinsight.com/sample-request/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Methylmalonic Acidemia Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies -Logic Biotherapeutics, Moderna, HemoShear Therapeutics, Target Pharma Solutions. here
News-ID: 3125344 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Methylmalonic
Methylmalonic Acidemia Market trends, Diagnosis, and Treatment Landscape
Methylmalonic Acidemia (MMA) is a rare inherited metabolic disorder resulting from defects in the metabolism of certain amino acids, cholesterol, and fatty acids. It is typically caused by mutations in genes responsible for the enzyme methylmalonyl-CoA mutase or related pathways. Patients with MMA are unable to properly break down specific compounds, leading to accumulation of toxic substances in the blood, which can result in developmental delays, recurrent metabolic crises, and…
Methylmalonic Acid Market: An In-Depth Analysis
In 2024, the market was valued at approximately USD 250 million and is projected to reach around USD 400 million by 2033, reflecting a compound annual growth rate (CAGR) of 5.5% from 2025 to 2033.
Methylmalonic Acid Market Overview
Methylmalonic acid serves as a crucial biomarker in clinical settings, aiding in the diagnosis of conditions such as methylmalonic acidemia and other vitamin B12-related disorders. The market's growth is fueled by the rising…
Methylmalonic Acidemia (MMA) Market Size Projected To Reach $12.5 Billion By 203 …
The Methylmalonic Acidemia (MMA) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Methylmalonic Acidemia (MMA) Market?
The market for methylmalonic acidemia (MMA) has experienced robust growth in the past few years. The size of the market is forecasted to…
Methylmalonic Acidemia Market 2023 Trends, Top Industry Players and Future Trend …
"According to the research report, the global methylmalonic acidemia market was valued at USD 9.16 billion in 2022 and is expected to reach USD 14.78 billion by 2032, to grow at a CAGR of 5.0% during the forecast period."
Get Sample with Latest Trends and Future Advancements @ https://www.polarismarketresearch.com/industry-analysis/methylmalonic-acidemia-market/request-for-sample
Polaris Market Research has recently published its latest analysis on Methylmalonic Acidemia Market 2023: By Types, Applications, Size, Share, Key Players & Regions…
Methylmalonic Acid Market Will Generate Record Revenue by 2029
The Methylmalonic Acid Market is anticipated to grow at a significant CAGR during the forecast period. Methylmalonic acid (MMA) is a substance created by the human body when it digests protein. The amount of vitamin B12 in the body controls the production of MMA in the body. A high amount of MMA typically means a deficiency of vitamin B12.?The major factor driving the growth of the market during the forecast…
Methylmalonic Acidemia Market to Show a Rise During the Forecast Period asserts …
DelveInsight's "Methylmalonic Acidemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Methylmalonic Acidemia, historical and forecasted epidemiology as well as the Methylmalonic Acidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Methylmalonic Acidemia market report provides current treatment practices, emerging drugs, Methylmalonic Acidemia market share of the individual therapies, and current and forecasted Methylmalonic Acidemia market size…
